Retirement Planning Co of New England Inc. Takes Position in Agilent Technologies, Inc. $A

Key Points

• Retirement Planning Co of New England Inc. has acquired 2,766 shares of Agilent Technologies, valued at approximately $324,000, reflecting growing institutional interest in the company.
• Multiple analysts have varying views on Agilent's stock, with price targets ranging from $128.00 to $155.00, highlighting a consensus average target of $139.25.
• Agilent Technologies reported quarterly earnings of $1.37 per share, matching expectations, with a revenue increase of 10.1% year-over-year.

Retirement Planning Co of New England Inc. acquired a new stake in Agilent Technologies, Inc. (NYSE:A - Free Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 2,766 shares of the medical research company's stock, valued at approximately $324,000.

Other large investors have also recently made changes to their positions in the company. Sunbelt Securities Inc. lifted its stake in shares of Agilent Technologies by 640.0% in the fourth quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company's stock valued at $30,000 after buying an additional 192 shares in the last quarter. Whipplewood Advisors LLC lifted its stake in shares of Agilent Technologies by 286.2% in the first quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock valued at $29,000 after buying an additional 186 shares in the last quarter. Wood Tarver Financial Group LLC bought a new position in shares of Agilent Technologies in the fourth quarter valued at $34,000. Stone House Investment Management LLC bought a new position in shares of Agilent Technologies in the first quarter valued at $30,000. Finally, Opal Wealth Advisors LLC bought a new position in shares of Agilent Technologies in the first quarter valued at $31,000.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. JPMorgan Chase & Co. dropped their price objective on shares of Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating on the stock in a research note on Thursday, May 29th. Leerink Partners raised their price target on shares of Agilent Technologies to $135.00 and gave the company a "buy" rating in a research report on Friday, May 30th. Wells Fargo & Company raised their price target on shares of Agilent Technologies from $135.00 to $140.00 and gave the company an "overweight" rating in a research report on Thursday, August 28th. UBS Group dropped their price target on shares of Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating on the stock in a research report on Thursday, May 29th. Finally, Barclays reissued an "equal weight" rating and set a $125.00 price target on shares of Agilent Technologies in a research report on Friday, August 29th. Six analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $139.25.

Agilent Technologies Stock Performance

A stock traded up $0.21 during mid-day trading on Friday, hitting $128.69. The company had a trading volume of 1,633,203 shares, compared to its average volume of 1,522,644. The firm has a market cap of $36.48 billion, a PE ratio of 30.21, a price-to-earnings-growth ratio of 4.00 and a beta of 1.24. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $153.84. The stock's fifty day moving average price is $119.22 and its two-hundred day moving average price is $116.34.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, hitting the consensus estimate of $1.37. The business had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company's revenue for the quarter was up 10.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of Agilent Technologies stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total value of $177,099.52. Following the sale, the chief executive officer owned 37,448 shares of the company's stock, valued at approximately $4,397,893.12. The trade was a 3.87% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.